Postoperative Delirium in Hip Fracture Patients

Risk factors for postoperative delirium in hip fracture patients.

Completed

Looking for future studies?

Key information

Conditions

Delirium Brain Diseases Central Nervous System Diseases Confusion Dementia Mental Disorders Nervous System Diseases Neurobehavioral Manifestations Neurocognitive Disorders Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ullevaal Hospital

Oslo, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

hip fracture
age 65 or older

Exclusion criteria

critical ill/ dying
aphasia

Treatment and study plan

Primary outcomes

Delirium/ no-delirium

Time frame: 5 days postoperative

Secondary outcomes

Severity of delirium, length of delirium, complications, comorbidity, one-year mortality.

Time frame: 5 days postoperative, one year

Sponsors and collaborators

Lead sponsor

Ullevaal University Hospital

Other

Registry information

Important dates

Study start: 2005
Study completion: 2007
First posted: Nov 28, 2007
Registry last updated: Nov 28, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed